http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Avinger (AVGR) Prices Up to $24M Share and Warrant Offering at $1.66/sh
-
Avinger Announces Pricing of up to $24 Million Public Offering
-
Avinger Announces Pricing of up to $24 Million Public Offering
-
Avinger (AVGR) Increases Focus on Coronary Development, Cuts Costs
-
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
-
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
-
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
-
Avinger Reports First Quarter 2024 Results
-
Avinger to Announce First Quarter 2024 Results on May 15, 2024
-
Avinger Reports Fourth Quarter and Full Year 2023 Results
-
Avinger to Announce Full Year 2023 Results on March 20, 2024
-
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
-
Avinger Reports Third Quarter 2023 Results
-
Avinger to Announce Third Quarter 2023 Results on October 26
-
Avinger (AVGR) Raises $5.3 Million via At-The-Market Facility of Common Stock
-
Avinger Raises $5.3 Million via At-The-Market Facility
-
Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device
-
Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023
-
Avinger (AVGR) Announces Conversion of 12% of CRG Term Debt into Equity
-
Avinger Announces Conversion of 12% of CRG Term Debt into Equity
-
Avinger to Announce Second Quarter 2023 Results on July 27
-
Avinger Announces Presentations by Key Opinion Leaders at LINC 2023
-
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
-
Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System
-
Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device
-
Avinger Reports First Quarter 2023 Results
-
Avinger to Announce First Quarter 2023 Results on May 10
-
Avinger (AVGR) Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System
-
Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System
-
Avinger Reports Fourth Quarter 2022 Results
-
Avinger to Announce Fourth Quarter 2022 Results on March 15
-
Avinger (AVGR) Announces 510(k) Filing of Pantheris LV
-
Avinger Announces 510(k) Filing of Pantheris LV
-
Avinger Reports Third Quarter 2022 Results
-
Avinger (AVGR) Issued Seven New Patents for Its Proprietary Image-Guided Atherectomy Devices
-
Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices
-
Avinger to Announce Third Quarter 2022 Results on November 9
-
Avinger to Present at LD Micro Investor Conference
-
BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council
-
BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council
-
Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022
-
Avinger Reports Second Quarter 2022 Results
-
Avinger, Inc. Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-the-Market Under Nasdaq Rules
-
Avinger to Announce Second Quarter 2022 Results on August 11
-
Avinger (AVGR) Announces $5 Million Registered Direct and Private Placement Offerings of Common Stock, Warrants
-
Avinger Announces $5 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
-
Avinger (AVGR) Files 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System
-
Avinger Announces Filing of 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System
-
Avinger Expands International Presence with First Commercial Shipment to Chile
-
Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022

